Bacterin International Holdings, a developer of bone graft material and anti-infective coatings for medical applications, is set to acquire Robinson MedSurg, a medical device distribution company focused primarily on maxillofacial and craniofacial surgery devices.
The proposed transaction will involve an initial exchange of Bacterin common stock valued at $1 million for all the assets of Robinson MedSurg, including approximately $500,000 of inventory, existing commercial agreements, and intellectual property, the company said. In addition, upon reaching certain revenue goals by Robinson MedSurg over a two-year period, additional Bacterin common stock valued at $1 million may be remitted to Robinson MedSurg.
Robinson MedSurg was founded by Randolph Robinson, MD, DDS. The company distributes implantable medical devices for maxillofacial, craniofacial, and orthopedic uses.
